Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Testori

Showing results (61-70 of 153) with videos related to

Pageof 16
Sort By:
Melanoma Research|March 10, 2015
Dacarbazine in combination with bevacizumab for the treatment of unresectable/metastatic melanoma: a phase II studyPier F Ferrucci, Ida Minchella, Massimo Mosconi, et al.
Journal of Surgical Oncology|August 23, 2011
Local and intralesional therapy of in-transit melanoma metastasesAlessandro Testori, Mark B Faries, John F Thompson, et al.
Journal of Translational Medicine|May 12, 2019
The great debate at "Melanoma Bridge 2018", Naples, December 1st, 2018Paolo A Ascierto, Paolo Bruzzi, Alexander Eggermont, et al.
Annals of Surgical Oncology|March 20, 2009
Desmoid tumors of the anterior abdominal wall: results from a monocentric surgical experience and review of the literatureEmilio Bertani, Antonio Chiappa, Alessandro Testori, et al.
Endocrine|March 1, 2017
Erratum to: Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenibVincenzo Marotta, Concetta Sciammarella, Mario Capasso, et al.
Journal of Surgical Oncology|April 15, 2006
Primary and recurrent retroperitoneal soft tissue sarcoma: prognostic factors affecting survivalAntonio Chiappa, Andrew P Zbar, Emilio Bertani, et al.
Melanoma Research|November 18, 2008
Modification of lymphoscintigraphic sentinel node identification before and after excisional biopsy of primary cutaneous melanomaGiuseppe Trifirò, Francesco Verrecchia, Javier Soteldo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 21, 2016
Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivityAlexander M M Eggermont, Stefan Suciu, Piotr Rutkowski, et al.
Journal of Translational Medicine|May 5, 2012
The role of BRAF V600 mutation in melanomaPaolo A Ascierto, John M Kirkwood, Jean-Jacques Grob, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2015
Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guidelinePhilippe Saiag, Jean-Jacques Grob, Celeste Lebbe, et al.
Pageof 16

Showing results (61-70 of 153) with videos related to

Sort By:
Pageof 16
Melanoma Research|March 10, 2015
Dacarbazine in combination with bevacizumab for the treatment of unresectable/metastatic melanoma: a phase II studyPier F Ferrucci, Ida Minchella, Massimo Mosconi, et al.
Journal of Surgical Oncology|August 23, 2011
Local and intralesional therapy of in-transit melanoma metastasesAlessandro Testori, Mark B Faries, John F Thompson, et al.
Journal of Translational Medicine|May 12, 2019
The great debate at "Melanoma Bridge 2018", Naples, December 1st, 2018Paolo A Ascierto, Paolo Bruzzi, Alexander Eggermont, et al.
Annals of Surgical Oncology|March 20, 2009
Desmoid tumors of the anterior abdominal wall: results from a monocentric surgical experience and review of the literatureEmilio Bertani, Antonio Chiappa, Alessandro Testori, et al.
Endocrine|March 1, 2017
Erratum to: Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenibVincenzo Marotta, Concetta Sciammarella, Mario Capasso, et al.
Journal of Surgical Oncology|April 15, 2006
Primary and recurrent retroperitoneal soft tissue sarcoma: prognostic factors affecting survivalAntonio Chiappa, Andrew P Zbar, Emilio Bertani, et al.
Melanoma Research|November 18, 2008
Modification of lymphoscintigraphic sentinel node identification before and after excisional biopsy of primary cutaneous melanomaGiuseppe Trifirò, Francesco Verrecchia, Javier Soteldo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 21, 2016
Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivityAlexander M M Eggermont, Stefan Suciu, Piotr Rutkowski, et al.
Journal of Translational Medicine|May 5, 2012
The role of BRAF V600 mutation in melanomaPaolo A Ascierto, John M Kirkwood, Jean-Jacques Grob, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2015
Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guidelinePhilippe Saiag, Jean-Jacques Grob, Celeste Lebbe, et al.
Pageof 16